Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Cancer Survival Analysis01:21

Cancer Survival Analysis

805
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
805

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enzalutamide Monotherapy for the Treatment of Prostate Cancer with High-Risk Biochemical Recurrence: EMBARK Secondary End Points: Erratum.

The Journal of urology·2026
Same author

Evidence Thresholds for Novel Therapeutic Strategies in Prostate Cancer: A Consensus Statement from the Prostate Cancer Committee of the French Urological Association.

The French journal of urology·2026
Same author

Experimental and simulated <math><semantics><mrow><msub><mi>H</mi> <mn>2</mn></msub> <msub><mi>O</mi> <mn>2</mn></msub></mrow> <annotation>${{{\mathrm{H}}}_2}{{{\mathrm{O}}}_2}$</annotation></semantics></math> in pure water under conventional and ultra-high dose rates for single pulse proton irradiation.

Medical physics·2026
Same author

[Reirradiation: A new therapeutic paradigm in oncology].

Bulletin du cancer·2026
Same author

Study Protocol of OLIGOPELVIS 2-GETUG P12: A Randomized Phase 3 Study Comparing Intermittent Androgen-deprivation Therapy with or Without Salvage High-dose Intensity-modulated Radiotherapy to Oligorecurrent Pelvic and Para-aortic Lymph Nodes in Patients with Biochemically Relapsing Prostate Cancer.

European urology oncology·2026
Same author

Integrated Platforms to Further Advance Space Biology Research.

Methods in molecular biology (Clifton, N.J.)·2026

Related Experiment Video

Updated: Mar 2, 2026

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
05:39

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Published on: April 5, 2024

1.3K

Optimizing radiotherapy protocols using computer automata to model tumour cell death as a function of oxygen

Perrine Paul-Gilloteaux1, Vincent Potiron2, Grégory Delpon2,3

  • 1Structure Fédérative de Recherche François Bonamy, Micropicell, CNRS, INSERM, Université de Nantes, Nantes, France.

Scientific Reports
|May 25, 2017
PubMed
Summary

This study introduces a computer model to optimize hypofractionation radiotherapy. The model predicts that adjusting daily radiation dose based on tumor hypoxia can improve tumor control.

More Related Videos

3D Cell-Printed Hypoxic Cancer-on-a-Chip for Recapitulating Pathologic Progression of Solid Cancer
10:51

3D Cell-Printed Hypoxic Cancer-on-a-Chip for Recapitulating Pathologic Progression of Solid Cancer

Published on: January 5, 2021

5.2K
Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance
07:07

Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance

Published on: February 14, 2025

3.9K

Related Experiment Videos

Last Updated: Mar 2, 2026

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
05:39

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

Published on: April 5, 2024

1.3K
3D Cell-Printed Hypoxic Cancer-on-a-Chip for Recapitulating Pathologic Progression of Solid Cancer
10:51

3D Cell-Printed Hypoxic Cancer-on-a-Chip for Recapitulating Pathologic Progression of Solid Cancer

Published on: January 5, 2021

5.2K
Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance
07:07

Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance

Published on: February 14, 2025

3.9K

Area of Science:

  • Radiation Oncology
  • Computational Biology
  • Medical Physics

Background:

  • Hypofractionation, a radiotherapy technique, is increasingly adopted due to technological advancements.
  • Optimizing the efficacy of hypofractionation requires a deeper understanding of tumor response and microenvironment.
  • Current methods for predicting treatment outcomes need refinement for personalized radiotherapy.

Purpose of the Study:

  • To develop and validate a computational model for in silico testing of radiotherapy protocols.
  • To simulate cellular responses to ionizing radiation, considering tumor resistance and microenvironment heterogeneity.
  • To optimize hypofractionation strategies by predicting treatment efficacy based on tumor hypoxia.

Main Methods:

  • A computer model combining automata and image processing algorithms was developed.
  • The model simulates cellular responses to radiation, including altered oxygen permeabilization and mitotic catastrophe.
  • Model parameters were informed by published in vitro and in vivo data, and validated against murine prostate tumor xenografts.

Main Results:

  • The computational model successfully simulated tumor response to radiation.
  • Model validation against in vivo data confirmed its predictive capabilities.
  • Simulations predicted that adjusting daily radiation dose according to tumor hypoxia can optimize treatment efficacy.

Conclusions:

  • The developed computer model serves as a valuable tool for optimizing radiotherapy protocols.
  • Hypofractionation efficacy can potentially be enhanced by tailoring radiation dosage to tumor hypoxia levels.
  • Further refinement of this model will facilitate the development of advanced radiotherapy strategies.